Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 11/07/2025

98,18 USD (+1,57%)

(+1,57%) 11/07/2025

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d 1,57%
1 week1w 1,27%
1 maand1m 1,34%
3 maanden3m 38,22%
6 maanden6m 42,43%
1 jaar1j 27,99%
5 jaar5j 272,60%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

8 mei 2025 · Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update · Persbericht

29 april 2025 · Insmed To Present at the BofA Securities 2025 Health Care Conference · Persbericht

24 april 2025 · Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028 · Persbericht

23 april 2025 · New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis · Persbericht

23 april 2025 · Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 · Persbericht

25 maart 2025 · Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference · Persbericht

10 maart 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

6 september 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

8 augustus 2024 · Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update · Persbericht

2 augustus 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

CEO: William Lewis

Werknemers: 778

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe